TrialCPT: pharmacometrics & systems pharmacology2020

Kinetic-Pharmacodynamic Model of Platelet Time Course in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib.

Elena Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.